| Serial Number | 79334635 |
| Word Mark | OLIX |
| Filing Date | Friday, December 24, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 9, 2024 |
| Registration Number | 7435162 |
| Registration Date | Tuesday, July 9, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 23, 2024 |
| Goods and Services | Dietary supplements; nucleic acid sequences for medical purposes; cultures of microorganisms for medical use; biotechnological preparations for medical use, namely, cells, recombinant DNA sequences, synthetic RNA sequences, and oligonucleotides for use in treating and repairing damaged human tissue through tissue nanotransfection (TNT); reagent paper for medical purposes; drugs for medical purposes, namely, cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, metabolic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; synthetic peptides for the treatment of metabolic, ophthalmic, cardiovascular, pulmonary, hepatological, respiratory, neurological diseases and disorders; cardiovascular pharmaceuticals, anti-diabetic pharmaceuticals, antibacterial pharmaceuticals, macular degeneration treatment pharmaceuticals (or ophthalmic pharmaceuticals), hair loss treatment pharmaceuticals, hepatitis treatment pharmaceuticals, respiratory disease treatment pharmaceuticals, neurological disease treatment pharmaceuticals, hepatological disease treatment pharmaceuticals; materials for dental fillings; colostral antibodies for medical purposes, monoclonal antibodies for medical purposes, hybrid antibodies for medical purposes; all the foregoing for human use and excluding goods related to the care and feeding of animals and plants |
| Goods and Services | Product research and development in the field of biotech technology; scientific research in the field of biotechnology, medical research in the field of biotechnology; scientific research and scientific investigations for medical purposes in the field of biomedicine; scientific research consultation and providing scientific research information both of the foregoing in the field of biomedicine; bacteriological research; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; pharmaceutical research services; scientific research in the field of genetics; medical research laboratory services; Scientific research and scientific investigations for medical purposes, both of the foregoing in the fields of medicine, health and pharmacology; medical research; All the above-mentioned services excluding services related to the care and feeding of animals and plants |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 10, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 10, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | OliX Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | OliX Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | OliX Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Thursday, March 3, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, March 10, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 15, 2022 | APPLICATION FILING RECEIPT MAILED |
| Saturday, July 23, 2022 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Wednesday, September 28, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, September 28, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, September 29, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, October 1, 2022 | LIMITATION OF GOODS RECEIVED FROM IB |
| Friday, October 28, 2022 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Monday, December 12, 2022 | REFUSAL PROCESSED BY MPU |
| Monday, December 12, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, January 4, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, January 12, 2023 | LIMITATION FROM THE IB - REQUEST EXAM REVIEW |
| Wednesday, February 1, 2023 | ATTORNEY REVIEW COMPLETED |
| Tuesday, May 2, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 2, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 3, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 24, 2023 | FINAL REFUSAL WRITTEN |
| Wednesday, May 24, 2023 | FINAL REFUSAL E-MAILED |
| Wednesday, May 24, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, November 21, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, November 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, December 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, January 8, 2024 | ACTION CONTINUING A FINAL - COMPLETED |
| Monday, January 8, 2024 | CONTINUATION OF FINAL REFUSAL E-MAILED |
| Monday, January 8, 2024 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
| Saturday, January 13, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, February 6, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, February 6, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 12, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 10, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 10, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, April 23, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Monday, April 29, 2024 | NOTIFICATION PROCESSED BY IB |